Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

Trine Zeeberg  Buch-Hansen; Rikke Bæk Sørensen; A. Mellemgaard; P.T. Straten; M.H. Andersen; I.M. Svane

Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

Trine Zeeberg Buch-Hansen, Rikke Bæk Sørensen, A. Mellemgaard, P.T. Straten, M.H. Andersen, I.M. Svane

Department of Oncology

Original language	English
Journal	Journal of Immunotherapy
Volume	33
Issue number	8
Pages (from-to)	919-920
Number of pages	2
ISSN	1524-9557
Publication status	Published - 2010

Cite this

Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, M. H., & Svane, I. M. (2010). Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial. Journal of Immunotherapy, 33(8), 919-920.

Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial. / Buch-Hansen, Trine Zeeberg ; Sørensen, Rikke Bæk; Mellemgaard, A. et al.
In: Journal of Immunotherapy, Vol. 33, No. 8, 2010, p. 919-920.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Buch-Hansen, TZ, Sørensen, RB, Mellemgaard, A, Straten, PT , Andersen, MH & Svane, IM 2010, 'Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial', Journal of Immunotherapy, vol. 33, no. 8, pp. 919-920.

Buch-Hansen TZ, Sørensen RB, Mellemgaard A, Straten PT , Andersen MH , Svane IM. Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial. Journal of Immunotherapy. 2010;33(8):919-920.

Buch-Hansen, Trine Zeeberg ; Sørensen, Rikke Bæk ; Mellemgaard, A. et al. / Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial. In: Journal of Immunotherapy. 2010 ; Vol. 33, No. 8. pp. 919-920.

@article{53c8614209164e92b133990d841f4069,

title = "Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial",

author = "Buch-Hansen, \{Trine Zeeberg\} and S{\o}rensen, \{Rikke B{\ae}k\} and A. Mellemgaard and P.T. Straten and M.H. Andersen and I.M. Svane",

year = "2010",

language = "English",

volume = "33",

pages = "919--920",

journal = "Journal of Immunotherapy",

issn = "1524-9557",

publisher = "Lippincott Williams and Wilkins",

number = "8",

}

TY - ABST

T1 - Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

AU - Buch-Hansen, Trine Zeeberg

AU - Sørensen, Rikke Bæk

AU - Mellemgaard, A.

AU - Straten, P.T.

AU - Andersen, M.H.

AU - Svane, I.M.

PY - 2010

Y1 - 2010

M3 - Conference abstract in journal

SN - 1524-9557

VL - 33

SP - 919

EP - 920

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

IS - 8

ER -